COVID-19

Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.

FDA revises emergency use authorization to grant prescribing authority for Pfizer’s Paxlovid antiviral treatment for COVID-19.

The value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.

Patients could have a better immune response against the omicron variant of COVID-19 with a second booster of the bivalent mRNA-1273.214 vaccine at a 50 μg dose.

Take steps to safeguard prescribing, dispensing, and patient use of the COVID-19 antiviral medication.

Pfizer and BioNTech have also initiated a phase 1/2/3 study evaluating the safety, tolerability, and immunogenicity of different doses and dosing regimens with the vaccine in children.

The data showed moral concerns about fairness, loyalty, and purity influenced county-level vaccination rates, but care and authority did not.

Analyses of more than 30,000 adults in the United Kingdom from 9 prospective cohort studies finds a high pre-pandemic BMI was associated with the infection.

In a recent study, researchers observed that more than one-third of children with a primary immunodeficiency disease died from COVID-19.

While the performance of nasal self-sampling rapid antigen tests for COVID-19 was found to decrease over time, adding oropharyngeal may improve its performance.

Men with chronically low testosterone levels are more likely to be hospitalized from COVID-19 than those with normal levels, but testosterone therapy could decrease this risk.

Investigators find 8 of 10 of the most common symptoms were reported between 50% and 80% less often among those who received at least 2 Pfizer-BioNTech vaccinations.

Receiving 3 doses of the COVID-19 vaccine can offer better and more long-lasting protection against the Omicron variant.

Viral antigen levels in blood plasma can provide clinically important patient outcomes among hospitalized patients with COVID-19.

The percentage of infections, hospitalizations, and deaths that were prevented from COVID-19 vaccination increased with greater vaccine coverage, according to a recent study.

Children younger than age 6 years might be protected from other COVID-19 variants for up to a year after infection.

Pharmacists handle public vaccination efforts and need to assess where patients are on the hesitancy spectrum to provide reliable information.

Findings have implications for patients who take supplementary folate to prevent complications of other pharmacological therapies.

Researchers suggest that understanding the incubation period of COVID-19 and its individual strains could determine the isolation period.

Doug Long and Scott Biggs of IQVIA discussed how data from Australia can help predict the strength of the upcoming flu season.

Researchers suggest that more public health measures should be taken to address disparities among adults boosted for COVID-19.

The COVID-19 pandemic impacted people experiencing homeless, though estimates remain unknown and highlights a need for more inclusive data.

School-aged children that self-swabbed for COVID-19 did so with almost as much accuracy as a health care provider, which could ease strain on school health care systems.

With these bivalent vaccine authorizations, the monovalent mRNA COVID-19 vaccines are still not authorized as booster doses for individuals 12 years of age and older.

Analysis from the Johns Hopkins Children’s Center and University of Colorado indicates that cancellation of sports and a switch to virtual learning likely increased this risk.